ACOR Acorda Therapeutics Inc

7,657

$10.32

$0.5185

(5.29%)

Today

Watchers	7,657
52-Wk Low	$8.98
52-Wk High	$24.20

Market Cap	$70.01M
Volume (M)	3,324.00
52-Wk High	$24.20
52-Wk Low	$8.98

Fundamentals

Acorda Therapeutics Reports Third Quarter 2023 Financial ResultsBusiness Wire • 20 days ago

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today provided a business update and reported its financial results for the third quarter ended September 30, 2023. We were pleased to see a 32% increase in...

Share to Feed

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023Business Wire • 27 days ago

Acorda Therapeutics, Inc. (Nasdaq: ACOR) will host a webcast/conference call in conjunction with its third quarter 2023 update and financial results on Monday, November 13 at 4:30 p.m. ET. To...

Acorda Therapeutics submits new regulatory filings for approval of InbrijaThe Fly • 27 days ago

See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJABusiness Wire • 27 days ago

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced the submission of new regulatory filings for the approval of INBRIJA (levodopa inhalation powder) in six countries in Latin America by its...

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Sees Large Increase in Short InterestZolmax • about 1 month ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR Get Free Report) was the target of a large growth in short interest in October. As of October 15th, there was short interest totalling 14,600 shares, a...

Acorda Therapeutics (NASDAQ:ACOR) Research Coverage Started at StockNews.comTicker Report • about 2 months ago

StockNews.com started coverage on shares of Acorda Therapeutics (NASDAQ:ACOR Free Report) in a report published on Thursday morning. The brokerage issued a buy rating on the biopharmaceutical...

Acorda Therapeutics (NASDAQ:ACOR) Share Price Crosses Above 200 Day Moving Average of $13.34Zolmax • 2 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR Get Free Report)s share price crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of...

Acorda Therapeutics (NASDAQ:ACOR) Shares Cross Above 200-Day Moving Average of $13.62Zolmax • 3 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR Get Free Report)s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving...

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Sees Significant Decrease in Short InterestZolmax • 3 months ago

Acorda Therapeutics, Inc. (NASDAQ:ACOR Get Free Report) was the target of a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 12,900 shares, a drop of 21.3% from the July 31st total of 16,400 shares. Based on an average trading volume of...